The advent of highly active antiretroviral therapy (HAART) has led to significant reductions in morbidity and mortality; however, adverse effects are common, and may lead to discontinuation of therapy, dose interuption, and significant reductions in quality of life. Prompt identification and management of adverse effects are crucial to ensuring adherence to treatment and the success … Read more
Archive Active Surveillance
Swaziland Medicines Safety Watch
In collaboration with the National TB Control Program and the National AIDS Program, Swaziland’s Pharmacovigilance Centre launched the first Tuberculosis (TB) and HIV Active Surveillance System at six pilot sites in May 2013. The Swaziland Medicines Safety Watch provides safety reports and information on the implementation of the active surveillance activity.